Russell Investments Group
RNAM

Russell Investments Group’s Avidity Biosciences RNAM Stock Holding History

Russell Investments Group’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-37,523
Closed -$2.71M – 4305
2025
Q4 		$2.71M Sell
37,523
-167,941
-82% -$10.8M ﹤0.01% 1704
2025
Q3 		$8.95M Buy
205,464
+203,702
+11,561% +$8.23M 0.01% 962
2025
Q2 		$50K Sell
1,762
-2,616
-60% -$78K ﹤0.01% 2980
2025
Q1 		$129K Buy
4,378
+2,621
+149% +$81.6K ﹤0.01% 2701
2024
Q4 		$51.1K Hold
1,757
– – ﹤0.01% 2820
2024
Q3 		$80.7K Sell
1,757
-4,612
-72% -$200K ﹤0.01% 2701
2024
Q2 		$260K Buy
+6,369
New +$183K ﹤0.01% 2408
2021
Q3 		– Sell
-8,254
Closed -$203K – 3184
2021
Q2 		$203K Hold
8,254
– – ﹤0.01% 2907
2021
Q1 		$180K Buy
8,254
+1,035
+14% +$25.3K ﹤0.01% 2860
2020
Q4 		$184K Buy
+7,219
New +$211K ﹤0.01% 2781

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Russell Investments Group's RNAM Position: Q1 2026 in Review

Russell Investments Group sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 37,523 shares — an estimated $2.71M sold.

Russell Investments Group first reported a position in RNAM in Q4 2020 and held it in 10 quarters. The position peaked at $8.95M in Q3 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Russell Investments Group reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Russell Investments Group sold 37,523 Avidity Biosciences shares in Q1 2026, an estimated $2.71M.
  • Russell Investments Group first reported a position in Avidity Biosciences in Q4 2020 and held it in 10 quarters.
  • Russell Investments Group's Avidity Biosciences position peaked at $8.95M in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.